Rapport Therapeutics, Inc. (RAPP)
40.45
-1.50
(-3.58%)
USD |
NASDAQ |
Sep 18, 16:00
40.40
-0.05
(-0.13%)
After-Hours: 20:00
Rapport Therapeutics Total Assets (Quarterly) : 458.98M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 458.98M |
| March 31, 2026 | 497.60M |
| December 31, 2025 | 512.43M |
| September 30, 2025 | 535.32M |
| June 30, 2025 | 285.50M |
| March 31, 2025 | 302.05M |
| Date | Value |
|---|---|
| December 31, 2024 | 314.93M |
| September 30, 2024 | 331.14M |
| June 30, 2024 | 346.10M |
| March 31, 2024 | 206.29M |
| December 31, 2023 | 155.42M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 36.06M |
| Shareholders Equity (Quarterly) | 422.93M |
| Debt to Equity Ratio | 0.0239 |
| Current Ratio | 15.72 |
| Net Debt Paydown Yield | -0.02% |